Seong A Kim Selected Research

Immunotherapy

4/2024	Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity.
1/2023	Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy.
11/2022	Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.
12/2021	Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma.
11/2021	Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential.
1/2021	In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
12/2020	Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seong A Kim Research Topics

Disease

11	Neoplasms (Cancer) 04/2024 - 01/2019
1	COVID-19 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Anemia 11/2022
1	Thrombocytopenia (Thrombopenia) 11/2022
1	Squamous Cell Carcinoma of Head and Neck 12/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Uveal melanoma 01/2021

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 01/2021
2	rho-Associated KinasesIBA 11/2021 - 01/2021
1	Therapeutic UsesIBA 04/2024
1	Cancer VaccinesIBA 04/2024
1	VaccinesIBA 04/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2024
1	AntigensIBA 01/2023
1	NucleolinIBA 01/2023
1	AntibodiesIBA 11/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022
1	Programmed Cell Death 1 ReceptorIBA 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	CalreticulinIBA 12/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	farnesyl pyrophosphate (farnesyl diphosphate)IBA 01/2021
1	Terpenes (Terpenoids)IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	K-115IBA 01/2021
1	geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2020
1	MicroRNAs (MicroRNA)IBA 12/2020
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2019

Therapy/Procedure

7	Immunotherapy 04/2024 - 12/2020
6	Therapeutics 12/2021 - 12/2020
1	Ligation 11/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2021